GOV’T IS DEVELOPING A PHARMACEUTICAL POLICY TO ATTRACT INVESTMENT-INDIA-GHANA PHARMA BUSINESS SUMMIT

GOV’T IS DEVELOPING A PHARMACEUTICAL POLICY TO ATTRACT INVESTMENT-INDIA-GHANA PHARMA BUSINESS SUMMIT

Deputy Minister of Trade and Industry, Hon. Michael Okyere Baafi has disclosed that the government is developing a pharmaceutical policy to be able to strategically attract investment in the area of pharmaceutical businesses in the country.

He said, Ghana is doing 30% of pharmaceutical businesses in the country and they have a lot to do to be able to meet the target of the 70% which needs to be filed in the pharmaceutical industry.

According to him, the Government through the policy of one district, one factory (1D1F) has advanced through the participation of financial institutions (PFIs) and has given out 415 million dollars in the form of loans to support the pharmaceutical industry to be able to operate well in this country.

GOV'T IS DEVELOPING A PHARMACEUTICAL POLICY TO ATTRACT INVESTMENT-INDIA-GHANA PHARMA BUSINESS SUMMIT

Speaking at the India-Ghana pharma business summit in Accra under the theme: Managing the economic challenges in the pharma business in Ghana, he said, Government holds the pharmaceutical industry in high esteem and cherishes their efforts in trying to champion the pharmaceutical industry in the country.

The Chairman of the Ghana national chamber of pharmacies, Pharm. Harrison Kofi Abutiate on his part said, they are happy the cedi is improving, and the positive impact is to reduce prices of medicines accordingly due to the stability of the cedis and they may also consider bringing the prices of their products down when they meet.

The India High Commission, H.E Sugandh Rajaram spoke about the purpose of the workshop and how pharmaceutical industries can improve in manufacturing.

Samuel Kwame Boadu, Administrative Officer & Digital Marketer at Ghana National Chamber of Pharmacy added that “The Summit along the exhibition provides the platform for pharmaceutical manufacturers, suppliers and importers to discuss ways to partner with each other to help catalyze the growth of the pharmaceutical industry and improve investment

Leave a Reply

Your email address will not be published. Required fields are marked *